NIVOLUMAB , PEMBROLIZUMAB , ATEZOLIZUMAB , DURVALUMAB , OBINUTUZUMAB, CEMIPLIMAB, DARATUMUMAB clinical trials

ETCABio - Evaluation of Skin Tests in Biotherapy Allergies

This study looks at how your skin reacts to certain advanced cancer medicines, called biotherapies. We're finding the strongest dose that doesn't cause a skin reaction in most people when tested on the skin, to make these treatments safer.